Neuro-Oncology Reviews

Volume 26 Number 29
20 December 2024

Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 29, 20 December

Palavani LB, Semione G, de Oliveira Almeida G, Lepine HL, Borges P, Nogueira BV, Lúcia G, Ferreira MY, Pereira A, Batista da Hora DA, de Jesus Leone Pereira M, Torregrossa F, Nigris Vasconcellos F, Bertani R, Bastianon R, Benjamin C, Formentin C.
Evaluating the safety and efficacy of proton radiotherapy for intracranial pediatric ependymomas: A single-arm meta-analysis.
J Clin Neurosci. 2024 Dec 11;132:110977. doi: 10.1016/j.jocn.2024.110977? PMID: 39662113. Review; Meta-anallysis˰ ˍ

Zhang Y, Zhang Q, Liu R, Zhang D, Hu G, Chen X.
Circadian disruption in cancer and regulation of cancer stem cells by circadian clock genes: An updated review.
Cancer Lett. 2024 Dec 11:217391. doi: 10.1016/j.canlet.2024.217391. PMID: 39672457. Review. ˍ

Toader C, Dumitru AV, Eva L, Serban M, Covache-Busuioc RA, Ciurea AV.
Nanoparticle Strategies for Treating CNS Disorders: A Comprehensive Review of Drug Delivery and Theranostic Applications.
Int J Mol Sci. 2024 Dec 11;25(24):13302. doi: 10.3390/ijms252413302. PMID: 39769066. Review. ˍ

Vachha BA, Kumar VA, Pillai JJ, Shimony J, Tanabe J, Sair HI.
Resting-State Functional MRI: Current State, Controversies, Limitations, and Future Directions-AJR Expert Panel Narrative Review.
AJR Am J Roentgenol. 2024 Dec 11. doi: 10.2214/AJR.24.32163. PMID: 39660823. Review˰ ˍ

Baskaran AB, Kozel OA, Venkatesh O, Wainwright DA, Sonabend AM, Heimberger AB, Lukas RV.
Immune Checkpoint Inhibitors in Glioblastoma IDHwt Treatment: A Systematic Review.
Cancers (Basel). 2024 Dec 12;16(24):4148. doi: 10.3390/cancers16244148. PMID: 39766048. Review. ˍ

Cong Y, Abulimiti M, Matsumoto Y, Jin J.
Current research trends and hotspots of boron neutron capture therapy: a bibliometric and visualization analysis.
Front Oncol. 2024 Dec 12;14:1507157. doi: 10.3389/fonc.2024.1507157. PMID: 39726703. Bibliometric analysis. ˍ

Mondia MWL, Hooks RE, Maragkos GA, Smith VL, McCord MR, Donahue JH, Williams ES, Lopes MB, Schiff D, Asthagiri AR.
Primary diffuse leptomeningeal glioblastoma: a case report and literature review.
J Neurooncol. 2024 Dec 12. doi: 10.1007/s11060-024-04908-8. PMID: 39666263. Case report; Review. ˍ

Murugan AK, Kannan S, Alzahrani AS.
TERT promoter mutations in gliomas: Molecular roles in tumorigenesis, metastasis, diagnosis, prognosis, therapeutic targeting, and drug resistance.
Biochim Biophys Acta Rev Cancer. 2024 Dec 12:189243. doi: 10.1016/j.bbcan.2024.189243. PMID: 39674418. Review˰ ˍ

Guru S, Lam FC, Akhavan-Sigari A, Hori YS, AbuReesh D, Tayag A, Emrich SC, Ustrzynski L, Park DJ, Chang SD.
"Beyond the Knife"-Applying Theranostic Technologies to Enhance Outcomes in Neurosurgical Oncology.
Brain Sci. 2024 Dec 13;14(12):1253. doi: 10.3390/brainsci14121253. PMID: 39766452. Review. ˍ

Juarez TM, Gill JM, Minev BR, Sharma A, Kesari S.
Neoadjuvant clinical trials in adults with newly diagnosed high-grade glioma: A systematic review.
Crit Rev Oncol Hematol. 2024 Dec 13;206:104596. doi: 10.1016/j.critrevonc.2024.104596. PMID: 39675399. Interventional; Review˰ ˍ

Taori S, Habib A, Adida S, Gecici NN, Sharma N, Calcaterra M, Tang A, Pandya S, Mehra A, Deng H, Elidrissy H, Idrissi YA, Amjadzadeh M, Zinn PO.
Circulating biomarkers in high-grade gliomas: current insights and future perspectives.
J Neurooncol. 2024 Dec 13. doi: 10.1007/s11060-024-04903-z. PMID: 39671020. Review˰ ˍ

**Schettini F, Pineda E, Rocca A, Buché V, Donofrio CA, Mazariegos M, Ferrari B, Tancredi R, Panni S, Cominetti M, Di Somma A, González J, Fioravanti A, Venturini S, Generali D.
Identifying the best treatment choice for relapsing/refractory glioblastoma: a systematic review with multiple Bayesian network meta-analyses.
Oncologist. 2024 Dec 14:oyae338. doi: 10.1093/oncolo/oyae338. PMID: 39674575. Interventional; Review; Meta-anallysis. ˍ

Pan J, Shao C, Tang H, Wu N.
Coffee and tea consumption and glioma risk: a meta-analysis of cohort studies.
Front Nutr. 2024 Dec 16;11:1506847. doi: 10.3389/fnut.2024.1506847. PMID: 39737152. Meta-analysis. ˍ

Tykocki T.
Diffuse intrinsic pontine glioma and CAR-T therapy: An Emerging Frontier.
World Neurosurg. 2024 Dec 16:123579? doi: 10.1016/j.wneu.2024.123579? PMID: 39694135. Review˰ ˍ

Gao S, Li X, Han B.
Bacterial and bacterial derivatives-based drug delivery systems: a novel approach for treating central nervous system disorders.
Expert Opin Drug Deliv. 2024 Dec 17. doi: 10.1080/17425247.2024.2444364. PMID: 39688950. Review˰ ˍ

Norollahi SE, Morovat S, Keymoradzadeh A, Hamzei A, Modaeinama M, Soleimanmanesh N, Soleimanmanesh Y, Najafizadeh A, Bakhshalipour E, Alijani B, Samadani AA.
Transforming Agents: The Power of Structural Modifications in Glioblastoma Multiforme Therapy.
Prog Biophys Mol Biol. 2024 Dec 17:S0079-6107(24)00106-8. doi: 10.1016/j.pbiomolbio.2024.12.001. PMID: 39701498. Review˰ ˍ

Yoo HB, Lee HH, Nga VDW, Choi YS, Lim JH.
Detecting Tumor-Associated Intracranial Hemorrhage Using Proton Magnetic Resonance Spectroscopy.
Neurol Int. 2024 Dec 17;16(6):1856-1877. doi: 10.3390/neurolint16060133. PMID: 39728759. Review. ˍ

Grewal EP, Nahed BV, Carter BS, Gerstner ER, Curry WT, Maus MV, Choi BD.
Clinical progress in the development of CAR T cells to treat malignant glioma.
J Neurooncol. 2024 Dec 18. doi: 10.1007/s11060-024-04909-7. PMID: 39695004. Interventional; Review˰ ˍ

Lu Y, Wang Z, Zhang D, Luo N, Yang H, Chen D, Huang H.
Application of Circulating Tumor DNA in the Auxiliary Diagnosis and Prognosis Prediction of Glioma.
Cell Mol Neurobiol. 2024 Dec 18;45(1):6. doi: 10.1007/s10571-024-01515-z. PMID: 39692767. Review. ˍ

Zhu Y, Carabenciov DD, Johnson DR, Trejo-Lopez JA, Nguyen AT, Raghunathan A, Lanzino G, Ida CM, Zepeda-Mendoza CJ, Dasari S, Russler-Germain E, Dahiya S, Quezado M, Aldape K, Giannini C.
Molecular profile of adult primary leptomeningeal gliomatosis aligns with glioblastoma, IDH-wildtype.
Brain Pathol. 2024 Dec 18:e13326. doi: 10.1111/bpa.13326. PMID: 39692003. Observational study; Review. ˍ ˍ

Bangash AH, Poudel P, Alshuqayfi KM, Ahmed M, Akinduro OO, Essayed W, Salehi A, Ramos RG, Yassari R, Singh H, Sheehan JP, Esquenazi Y.
Treatment-induced ripple effect: a systematic review exploring the abscopal phenomenon in Glioblastoma multiforme.
J Neurooncol. 2024 Dec 19. doi: 10.1007/s11060-024-04912-y. PMID: 39699762. Review˰ ˍ

Ćwiklińska A, Przewodowska D, Koziorowski D, Szlufik S.
Innovative Approaches to Brain Cancer: The Use of Magnetic Resonance-guided Focused Ultrasound in Glioma Therapy.
Cancers (Basel). 2024 Dec 19;16(24):4235. doi: 10.3390/cancers16244235. PMID: 39766134. Review. ˍ

Das S, Ahlawat S, Sarangi J, Gupta RK, Jain P, Kate U, Gogi R, Patir R.
Oligoastrocytoma: The Vanishing Entity With True Dual Genotype, a Report, its Molecular Profiles and Review of Literature.
Int J Surg Pathol. 2024 Dec 19:10668969241300503. doi: 10.1177/10668969241300503. PMID: 39699080. Case report; Review˰ ˍ

Dinakaran D, Moore-Palhares D, Yang F, Hill JB.
Precision radiotherapy with molecular-profiling of CNS tumours.
J Neurooncol. 2024 Dec 19. doi: 10.1007/s11060-024-04911-z. PMID: 39699761. Review˰ ˍ

Gaiaschi L, Bottone MG, De Luca F.
Towards Effective Treatment of Glioblastoma: The Role of Combination Therapies and the Potential of Phytotherapy and Micotherapy.
Curr Issues Mol Biol. 2024 Dec 19;46(12):14324-14350. doi: 10.3390/cimb46120859. PMID: 39727987. Review. ˍ

Gautam M, Gabrani R.
Current Combinatorial Therapeutic Aspects: The Future Prospect for Glioblastoma Treatment.
Curr Med Sci. 2024 Dec 19;44(6):1175-1184. doi: 10.1007/s11596-024-2950-7. PMID: 39695017. Review˰ ˍ

Park S, Maus MV, Choi BD.
CAR-T cell therapy for the treatment of adult high-grade gliomas.
NPJ Precis Oncol. 2024 Dec 19;8(1):279. doi: 10.1038/s41698-024-00753-0. PMID: 39702579. Review. ˍ

Perlow HK, Raleigh DR, Wang TJC, Pollom EL, Milano MT, Breen WG, Detsky J, Chang EL, Tom MC, Shiue KR, Lehrer EJ, Saeed H, Pike LRG, Lo SS, Mishra MV, Knisely JPS, Chao ST, Sahgal A, Palmer JD.
Consensus Radiation Treatment Planning Guidelines Utilizing (68)Ga-DOTATATE PET/CT for Resected Meningiomas.
Int J Radiat Oncol Biol Phys. 2024 Dec 19:S0360-3016(24)03726-X. doi: 10.1016/j.ijrobp.2024.12.003. PMID: 39701546. Guidelines˰ ˍ

Balasubramanian K, Kharbat AF, Call-Orellana F, Tavakol SA, Fassina GR, Janssen C, Bin Alamer O, Zuccato JA, Dunn IF.
Adult Cerebellopontine Angle Medulloblastoma: A Systematic Review of Clinical Features, Management Approaches, and Patient Outcomes.
Cancers (Basel). 2024 Dec 20;16(24):4242. doi: 10.3390/cancers16244242. PMID: 39766141. Review. ˍ

Erickson NJ, Stavarache M, Ibrahim T, Kaplitt MG, Markert JM.
Herpes Simplex Oncolytic Viral Therapy for Malignant Glioma and Mechanisms of Delivery.
World Neurosurg. 2024 Dec 20:123595? doi: 10.1016/j.wneu.2024.123595? PMID: 39710201. Review˰ ˍ

Sheikh SR, Klesse LJ, Mangum R, Bui A, Siegel BI, Abdelbaki MS, Patel NJ.
The role of MEK inhibition in pediatric low-grade gliomas.
Front Oncol. 2024 Dec 20;14:1503894. doi: 10.3389/fonc.2024.1503894. PMID: 39759151. Review. ˍ

Soleymani S, Doroudian M, Soezi M, Beladi A, Asgari K, Mobarakshahi A, Aghaeipour A, Macloughlin R.
Engendered nanoparticles for treatment of brain tumors.
Oncol Res. 2024 Dec 20;33(1):15-26. doi: 10.32604/or.2024.053069. PMID: 39735671. Review. ˍ

Westphal M, Levin VA, Berger MS, Pieper R, Nishikawa R, Bjerkvig R, Ashley DM, Bigner D, Sampson JH, Ichimura K, Rutka JT.
Advances in neuro-oncology: contributions of the Asilomar Conference on brain tumor research and therapy.
J Neurosurg. 2024 Dec 20:1-7. doi: 10.3171/2024.8.JNS241848. PMID: 39705690. Meeting report˰ ˍ